432 related articles for article (PubMed ID: 34566995)
1. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.
El Baba R; Herbein G
Front Immunol; 2021; 12():730765. PubMed ID: 34566995
[TBL] [Abstract][Full Text] [Related]
2. Battle between Host Immune Cellular Responses and HCMV Immune Evasion.
Manandhar T; Hò GT; Pump WC; Blasczyk R; Bade-Doeding C
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344940
[TBL] [Abstract][Full Text] [Related]
3. Subversion of Immune Response by Human Cytomegalovirus.
Patro ARK
Front Immunol; 2019; 10():1155. PubMed ID: 31244824
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.
Galitska G; Coscia A; Forni D; Steinbrueck L; De Meo S; Biolatti M; De Andrea M; Cagliani R; Leone A; Bertino E; Schulz T; Santoni A; Landolfo S; Sironi M; Cerboni C; Dell'Oste V
Front Immunol; 2021; 12():532484. PubMed ID: 33897679
[TBL] [Abstract][Full Text] [Related]
5. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
[TBL] [Abstract][Full Text] [Related]
6. The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.
Amsler L; Verweij M; DeFilippis VR
J Mol Biol; 2013 Dec; 425(24):4857-71. PubMed ID: 24013068
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
Noriega VM; Haye KK; Kraus TA; Kowalsky SR; Ge Y; Moran TM; Tortorella D
J Virol; 2014 Aug; 88(16):9391-405. PubMed ID: 24920803
[TBL] [Abstract][Full Text] [Related]
8. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.
Riou R; Bressollette-Bodin C; Boutoille D; Gagne K; Rodallec A; Lefebvre M; Raffi F; Senitzer D; Imbert-Marcille BM; Retière C
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031361
[TBL] [Abstract][Full Text] [Related]
9. The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.
Dassa L; Seidel E; Oiknine-Djian E; Yamin R; Wolf DG; Le-Trilling VTK; Mandelboim O
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950412
[TBL] [Abstract][Full Text] [Related]
10. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312
[TBL] [Abstract][Full Text] [Related]
11. Human cytomegalovirus induces and exploits Roquin to counteract the IRF1-mediated antiviral state.
Song J; Lee S; Cho DY; Lee S; Kim H; Yu N; Lee S; Ahn K
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18619-18628. PubMed ID: 31451648
[TBL] [Abstract][Full Text] [Related]
12. Tumors and Cytomegalovirus: An Intimate Interplay.
Herbein G
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458542
[TBL] [Abstract][Full Text] [Related]
13. Diverse immune evasion strategies by human cytomegalovirus.
Noriega V; Redmann V; Gardner T; Tortorella D
Immunol Res; 2012 Dec; 54(1-3):140-51. PubMed ID: 22454101
[TBL] [Abstract][Full Text] [Related]
14. CMV immune evasion and manipulation of the immune system with aging.
Jackson SE; Redeker A; Arens R; van Baarle D; van den Berg SPH; Benedict CA; Čičin-Šain L; Hill AB; Wills MR
Geroscience; 2017 Jun; 39(3):273-291. PubMed ID: 28647908
[TBL] [Abstract][Full Text] [Related]
15. A Prominent Role of the Human Cytomegalovirus UL8 Glycoprotein in Restraining Proinflammatory Cytokine Production by Myeloid Cells at Late Times during Infection.
Pérez-Carmona N; Martínez-Vicente P; Farré D; Gabaev I; Messerle M; Engel P; Angulo A
J Virol; 2018 May; 92(9):. PubMed ID: 29467314
[TBL] [Abstract][Full Text] [Related]
16. The Interplay between Human Cytomegalovirus and Pathogen Recognition Receptor Signaling.
Marques M; Ferreira AR; Ribeiro D
Viruses; 2018 Sep; 10(10):. PubMed ID: 30241345
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus immunity and immune evasion.
Jackson SE; Mason GM; Wills MR
Virus Res; 2011 May; 157(2):151-60. PubMed ID: 21056604
[TBL] [Abstract][Full Text] [Related]
18. How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future.
Sissons JG; Wills MR
Med Microbiol Immunol; 2015 Jun; 204(3):307-16. PubMed ID: 25896527
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
Rölle A; Olweus J
APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.
Gredmark-Russ S; Söderberg-Nauclér C
Virulence; 2012 Nov; 3(7):621-34. PubMed ID: 23076329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
